The Patent Finder

Techfields Pharma Co., Ltd.

11 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 27, 2026
    The maintenance fee for Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases (US 11,685,739) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 1 fee due May 14, 2027
    The maintenance fee for High Penetration Prodrug Compositions and Pharmaceutical Compoisiton Thereof for Treatment of Pulmonary Conditions (US 11,813,256) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary Conditions (US 11,857,545) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,786,497High penetration prodrug compositions of retinoids and retinoids-related compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,371,284Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 9,193,672High penetration prodrug compositions of retinoids and retinoid-related compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,969,751High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,485,744High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,376,381High penetration prodrug compositions of peptides and peptide-related compounds
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 11,541,029High Penetration Compositions and Their Applications
In force
 · High confidence
In forceHigh confidence
US 11,685,739Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases
In force
 · Medium confidence
In forceMedium confidence
US 11,857,545High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary Conditions
In force
 · Medium confidence
In forceMedium confidence
US 11,813,256High Penetration Prodrug Compositions and Pharmaceutical Compoisiton Thereof for Treatment of Pulmonary Conditions
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 7 lapsed for an unpaid fee · 4 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 3 abandoned · 10 no status recorded

Showing 1 to 10 of 14, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/400,716High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary ConditionsDec 29, 2023Abandoned
18/507,797High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary ConditionsNov 13, 2023Abandoned
18/488,616Oct 17, 2023No status recorded
18/097,486Jan 16, 2023No status recorded
18/147,171Dec 28, 2022No status recorded
18/051,060Oct 31, 2022No status recorded
18/049,041High Penetration Prodrug Compositions of Mustards and Mustard-Related CompoundsOct 24, 2022Abandoned
17/493,321Oct 4, 2021No status recorded
18/251,336Topical Administration of 2-(DIETHYLAMINO)ETHYL 2-(4-Isobutylphenyl)PROPRIONATE for Treatment of DiseasesJun 4, 2021Pending
16/421,735May 24, 2019No status recorded
10 of 14 applications shown.
Pro members see all 14 published applications.
Pro members: see all 14 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited